EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Short Term Loans and Advances History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Short Term Loans and Advances | ₹295 Cr | ₹239 Cr | ₹268 Cr | ₹267 Cr | ₹170 Cr |
What is the latest Short Term Loans and Advances ratio of EMCURE PHARMACEUTICALS ?
| Year | Short Term Loans and Advances |
|---|---|
| Mar2025 | ₹295 Cr |
| Mar2024 | ₹239 Cr |
| Mar2023 | ₹268 Cr |
| Mar2022 | ₹267 Cr |
| Mar2021 | ₹170 Cr |
How is Short Term Loans and Advances of EMCURE PHARMACEUTICALS Trending?
| Years | Short Term Loans and Advances | % Change | |
|---|---|---|---|
| Mar2025 | ₹295 Cr | 23.50 | |
| Mar2024 | ₹239 Cr | -10.62 | |
| Mar2023 | ₹268 Cr | 0.38 | |
| Mar2022 | ₹267 Cr | 56.85 | |
| Mar2021 | ₹170 Cr | - | |
Compare Short Term Loans and Advances of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹29,826.0 Cr | 3.4% | 12.6% | 14.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,019.0 Cr | -3.5% | -5.4% | -3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,752.0 Cr | -3.6% | 0.2% | 11.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,542.0 Cr | -0.5% | 5.9% | 20.3% | Stock Analytics | |
| CIPLA | ₹115,883.0 Cr | -1.8% | -4.8% | -1.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,024.7 Cr | -1.7% | -7.3% | -12.1% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | 3.4% |
12.6% |
14.3% |
| SENSEX | -1.9% |
-2.2% |
7.4% |
You may also like the below Video Courses